PE-22-28
Synthetic analogue of spadin that blocks the TREK-1 potassium channel, producing rapid antidepressant effects and stimulating hippocampal neurogenesis in
Buy more, save more
Total Price
$69
For research & laboratory use only. Not for human consumption.
Half-Life
~2-4 hours
Administration Route
Subcutaneous injection
Antidepressant Peptide
TREK-1 potassium channel blocker with antidepressant activity
Synaptogenesis
Promotes new synaptic connections in prefrontal cortex
Fast-Acting
Behavioural effects in rodents within hours of administration
Effect Profile
Focus & Memory
Neuroprotection
Mood & Anxiety
Neuroplasticity
Mechanism of Action
Scientific Research
Nat Neurosci (2010)
Neuropsychopharmacology (2016)
Nat Neurosci (2010)
Product FAQs
Stacks Well With
Selank
Synthetic heptapeptide anxiolytic developed by the Russian Academy of Sciences. Reduces anxiety without sedation, improves memory consolidation, and
Semax
ACTH(4-7) analogue with potent nootropic and neuroprotective properties. Upregulates BDNF and NGF, approved in Russia for stroke recovery and cognitive
NAD+
Nicotinamide adenine dinucleotide coenzyme found in every living cell. Substrate for sirtuins and PARP enzymes; declines with age. Studied for metabolic
Related Products
Selank
Synthetic heptapeptide anxiolytic developed by the Russian Academy of Sciences. Reduces anxiety without sedation, improves memory consolidation, and
Semax
ACTH(4-7) analogue with potent nootropic and neuroprotective properties. Upregulates BDNF and NGF, approved in Russia for stroke recovery and cognitive
DSIP
Neuropeptide that promotes slow-wave (delta) sleep, modulates cortisol and GH release, and demonstrates stress-reducing and potentially anti-cancer properties